Instructions for CME/NCPD: Complete the pre-test, listen to the
audio and view the slides, complete the post test, complete the
evaluation form and hit submit. You will be asked to enter your name
and email address on the pre-test, evaluation and post-test. If you
close your internet browser without completing the post test, you
will have ONE more opportunity to complete. A score of 70% must be
achieved on the post test to receive continuing education credits.
If you do not pass the post test after two attempts, you will not be
eligible to try again. Once you complete the evaluation form and
score 70% or higher on your post test, you will automatically be
given your certificate.
To print or save your certificate, you will need to click on the
“download” button and either print or save.
|
|
Audience:
This activity is intended for healthcare professionals practicing in
managed care environments.
This activity is supported by
an educational grant from
Jazz Pharmaceuticals
Description:
Excessive daytime sleepiness (EDS) is a common complaint in
individuals with obstructive sleep apnea (OSA) and narcolepsy.
Consequences of EDS include decreased cognitive functioning, work
productivity, and quality of life, and increased risk for
occupational and motor vehicle accidents. When factors such as
treatment adherence, medications, comorbid illness, and inadequate
sleep duration are controlled for, EDS is still reported in up to 6%
to 18% of people treated for sleep disorders, with EDS being a
persistent symptom. For most people, mild sleepiness is apparent
only during boring, sedentary situations, however patients with
narcolepsy, severe EDS, lead to involuntary somnolence during
regular activities that could put the patient and others in a
harmful situation, such as driving, eating, or talking.
Narcolepsy and OSA can interfere with psychological, social, and
cognitive function and development and can inhibit academic, work,
and social activities. With the potential danger surrounding
narcoleptic patients, it is important for clinicians to understand
and identify major sleep disorders and the best methods to diagnose
and treat them. Greater awareness of sleep disorders and its
symptoms can help accurately and efficiently diagnosis the disease.
As research continues to grow, better treatments for narcolepsy are
becoming available. Sleep studies are an essential part of the
evaluation and diagnosis of patients with narcolepsy. While in most
instances imaging studies do not give an accurate picture of what is
going on, a few studies done with an MRI can show structural
abnormalities of the brain that will help show what may be the
underlying cause of the sleep disorder. Symptoms can include EDS,
sleep paralysis, hallucinations, but cataplexy is the most specific
symptom and occurs in almost no other diseases. The combination of
an overnight polysomnogram (PSG) followed by a multiple sleep
latency test (MSLT) can provide the proper evidence of narcolepsy
while excluding other sleep disorders.
Upon completion of this
activity, participants will be able to:
-
Review the prevalence and impact of
excessive daytime sleepiness (EDS) and the burden that it places
on patients suffering from psychiatric disorders
-
Assess the diagnostic tools for the
identification and assessment of EDS in patients with
psychiatric disorders
-
Analyze the latest data on the
efficacy and safety of available and emerging therapies in
improving outcomes for EDS patients with narcolepsy or
obstructive sleep apnea
-
Discuss the role of a
multidisciplinary team to better communicate the goals of
treatment and utilize a shared decision-making approach to
optimize therapeutic outcomes
-
Evaluate an evidence-based strategy
to manage EDS in the context of psychiatric practice utilizing
general medical, cognitive/behavioral, and pharmacologic
techniques
-
Describe different considerations
involving clinical pathways and site of care initiatives for
optimal cost management and improved outcomes in EDS
|
Faculty: |
Michael J Thorpy, MD
Professor of Neurology
Albert Einstein College of Medicine
Director, Sleep-Wake Disorders Center
Montefiore Medical Center |
|
Disclosure:
|
(Relevant Financial Relationships with Ineligible
Companies in the Last 24 Months):
Dr. Thorpy has served as a consultant for Axsome,
Balance Therapeutics, Flamel/Avadel, Jazz
Pharmaceuticals, Suven Life Sciences Ltd., Idorsia
Pharmaceuticals and Eisai Pharmaceuticals, Takeda
Pharmaceutical Co., Ltd, NLS Pharmaceuticals, XW Pharma,
Harmony Biosciences, LLC, Jazz Pharmaceuticals. His
presentation has been reviewed for any bias. |
|
Planning Committee: |
Bill
Williams, MD has no relevant financial relationships
with an ineligible company in the last 24 months to
disclose.
Jeremy Williams has no relevant financial relationships
with an ineligible company in the last 24 months to
disclose.
Jacqueline Cole, RN, MS, CMCN has no relevant financial
relationships with an ineligible company in the last 24
months to disclose.
NAMCP and/or the presenter
has copyright or has received permissions for use of
materials provided in this activity. |
Accreditation & Designation
This activity has been planned and implemented in accordance with
the accreditation requirements and policies of the Accreditation
Council for Continuing Medical Education (ACCME) through the joint
providership of the National Association of Managed Care Physicians
(NAMCP) and American Association of Managed Care Nurses (AAMCN). The
National Association of Managed Care Physicians is accredited by the
ACCME to provide continuing medical education for physicians.
NAMCP designates this enduring material for a maximum of 1 AMA
PRA Category 1 credit(s)TM. Each
physician should claim credit commensurate with the extent of their
participation in the activity.
The American Association of Managed Care Nurses is accredited as a
provider of nursing continuing professional development by the
American Nurses Credentialing Center's Commission on Accreditation.
Nurses who complete this activity and achieve a passing score will
receive 1 hour in nursing continuing professional development.
This activity has been approved by the American Board of Managed
Care Nursing for 1.0 contact hours toward CMCN recertification
requirements.
This activity is supported by an educational grant from
Jazz Pharmaceuticals
NAMCP and/or this website does not
provide medical advice, diagnosis or treatment. NAMCP does not
endorse or imply endorsement of the content on any linked website.
This website is to be used as an informational resource. With any
health related concern, consult with your physician or healthcare
professional.
Click Here To Continue |